Anzeige
Mehr »
Samstag, 27.06.2026 - Börsentäglich über 12.000 News
Brasiliens Moment für seltene Erden ist gekommen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 859034 | ISIN: US1266501006 | Ticker-Symbol: CVS
Tradegate
26.06.26 | 21:16
91,24 Euro
-0,39 % -0,36
1-Jahres-Chart
CVS HEALTH CORPORATION Chart 1 Jahr
5-Tage-Chart
CVS HEALTH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
90,8891,0611:49
91,4891,7426.06.
ACCESS Newswire
374 Leser
Artikel bewerten:
(2)

CVS Health: A Second Chance at Life Through Heart Transplant and Ongoing Care

WOONSOCKET, RI / ACCESS Newswire / May 18, 2026 / Originally published on CVS Health Company Newsroom

Key points

  • After smoking for decades and surviving two heart attacks, Bill Allison learned that he needed a heart transplant - and that making immediate, lasting life changes was essential.

  • Beyond dispensing medications, Bill's CVS Specialty pharmacist, Amy Guard, has supported him throughout his post transplant journey with ongoing medication counseling and encouragement.

  • "Listen to your doctors, pharmacists and care team," Bill says. "It's never too late to change and turn your life around. I would do it again in a heartbeat."

After surviving two heart attacks, Bill Allison received news that stopped him in his tracks.

Unless he made immediate, lasting lifestyle changes and received a heart transplant, his doctor told him, he had little time left to live.

At age 65, Bill - a military veteran and retired truck driver from Waxhaw, North Carolina - made a decision that would change the course of his life. A longtime smoker, he quit cold turkey and stopped drinking alcohol.

"I realized I wanted to be around longer for my family and continue doing the things I love," Bill says. "I knew I needed to change."

While waiting for a donor heart, Bill focused on staying healthy and strong enough for surgery, knowing each day mattered.

Several months later, that opportunity arrived. In 2009, Bill underwent a successful heart transplant.

Today, at 81, Bill says he feels better than ever. He spends his days working on his more than two acre property, caring for his animals, and - most importantly - enjoying time with his wife of nearly 50 years, their children, and grandchildren.

"It's never too late for a second chance at life," he says.

The importance of long-term care

Bill is grateful to his organ donor and credits the many members of his health care team - physicians, surgeons, nurses, and pharmacists - who have supported him throughout his journey.

"I take a handful of prescription pills in the morning and a handful at night," Bill says. "And I go for regular checkups and monitoring with my doctor."

Those medications, including immunosuppressants, play a critical role in preventing organ rejection. For heart transplant recipients, medication adherence and ongoing monitoring are lifelong commitments essential to protecting the donated heart.

To help manage his ongoing care, Bill receives his specialty medications through CVS Specialty, with the option for convenient pickup at a nearby CVS Pharmacy-helping ensure dependable access to the life sustaining medications he has relied on over the years.

As part of that support, his CVS Specialty pharmacist, Amy Guard, PharmD, has been a consistent member of his care team, providing medication counseling and guidance to help him stay on track.

"Bill is remarkably resilient and motivated," Amy says. "Adhering to his medication regimen and maintaining a healthy lifestyle have been major factors in his long term success."

A message of hope - and the power of organ donation

Looking back, Bill says building a strong care support team - and listening to them - made all the difference.

He also hopes his story inspires others to consider organ donation.

"Organ donors are heroes," he says. "They can save lives and give people like me a future."

For anyone facing major health challenges, his advice is simple:

"Listen to your doctors, pharmacists, and care team," Bill says. "It's never too late to change and turn your life around. I would do it again in a heartbeat."

Find more stories and multimedia from CVS Health at 3blmedia.com.

Contact Info:
Spokesperson: CVS Health
Website: https://www.3blmedia.com/profiles/cvs-health
Email: info@3blmedia.com

SOURCE: CVS Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cvs-health-a-second-chance-at-life-through-heart-transplant-and-ongoi-1167715

© 2026 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.